Although neurological complications of SARS-CoV-2 infection are relatively rare, their
potential long term morbidity and mortality have a significant impact, given the large …

The COVID-19 pandemic has led to unprecedented demand on the global healthcare
system. Remarkably, at the end of 2021, COVID-19 vaccines received approvals for human …

Abstract Background The Global COVID Vaccine Safety (GCoVS) Project, established in
2021 under the multinational Global Vaccine Data Network™(GVDN®), facilitates …

Hospitalisation with COVID-19 is associated with an increased risk of neurological
sequelae; however, representative nationwide studies comparing to other infections with …

Objective The coronavirus disease 2019 (COVID-19) pandemic has demonstrated the value
of real-world data for public health research. International federated analyses are crucial for …

Background In view of accumulating case reports of thyroid dysfunction following COVID-19
vaccination, we evaluated the risks of incident thyroid dysfunction following inactivated …

Importance Bell palsy (BP) has been reported as an adverse event following the SARS-CoV-
2 vaccination, but neither a causative relationship nor a higher prevalence than in the …

Background Rapid deployment of COVID-19 vaccines is challenging for safety surveillance,
especially on adverse events of special interest (AESIs) that were not identified during the …

Introduction We investigated the potential association of COVID-19 vaccination with three
acute neurological events: Guillain-Barré syndrome (GBS), transverse myelitis and Bell's …

Purpose The primary aim of this work was to convert the Information System for Research in
Primary Care (SIDIAP) from Catalonia, Spain, to the Observational Medical Outcomes …